6 Results for "

paneth cell

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "paneth cell" in MCE Product Catalog:

Art. -Nr.: HY-103308
CAS. Nr.: 197525-99-8
Reinheit:  99.66%
Target:  

Potassium Channel

Forschungsgebiete:  

Neurological Disease

TRAM-39 is a selective blocker of intermediate conductance Ca2+-activated K+ (IKCa) channels. TRAM-39 inhibits KCa3.1 channel with an IC50 value of 60 nM. TRAM-39 can be used for the research of ataxia, epilepsy, memory disorders, schizophrenia and Parkinson’s disease .
loading...
    loading...
Art. -Nr.: HY-P5352
CAS. Nr.: 299157-43-0
Target:  

CD44

Forschungsgebiete:  

Inflammation/Immunology Cancer

Hyaluronan-IN-1 (Pep-1) is a Hyaluronan inhibitor with a Kd value of 1.65 μM. Hyaluronan-IN-1 blocks CD44-dependent cell adhesion. Hyaluronan-IN-1 inhibits cell adhesion to hyaluronan substrates. Hyaluronan-IN-1 suppresses the development of contact hypersensitivity in mice by blocking the homing process of inflammatory cells to the skin. Hyaluronan-IN-1 also inhibits responses during the sensitization phase. Hyaluronan-IN-1 reduces lung metastasis of melanoma and prolongs the survival of mice. Hyaluronan-IN-1 can be used in research related to contact hypersensitivity, chronic skin inflammation, and melanoma .
loading...
    loading...
Art. -Nr.: HY-103308R
CAS. Nr.: 197525-99-8
Forschungsgebiete:  

Neurological Disease

TRAM-39 (Standard) is the analytical standard of TRAM-39 (HY-103308). This product is intended for research and analytical applications. TRAM-39 is a selective blocker of intermediate conductance Ca2+-activated K+ (IKCa) channels. TRAM-39 inhibits KCa3.1 channel with an IC50 value of 60 nM. TRAM-39 can be used for the research of ataxia, epilepsy, memory disorders, schizophrenia and Parkinson’s disease .
loading...
    loading...
Art. -Nr.: HY-167182
CAS. Nr.: 470695-03-5
PUMAi is a PUMA inhibitor that disrupts the interaction between PUMA and BCL-xL. PUMAi inhibits apoptosis, caspase-3 activation, WNT/NOTCH pathway activation, and DNA damage. PUMAi protects intestinal tissues in mice, promotes the growth of colonoids, and reduces chemotherapy-induced weight loss, gastrointestinal damage, and lethality. PUMAi alleviates acetaminophen-induced liver injury and cytoplasmic translocation of HMGB1 in mice. PUMAi can be used in studies related to gastrointestinal injury, intestinal injury, and liver injury .
loading...
    loading...
Art. -Nr.: HY-P706028
Reinheit:  ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: Cyclin-dependent kinase 11B; cell division cycle 2-like protein kinase 1; CLK-1; cell division protein kinase 11B; Galactosyltransferase-associated protein kinase p58/GTA; PITSLRE serine/threonine-protein kinase CDC2L1; p58 CLK-1; CDC2L1; CDK11; PITSLREA; Cyclin-L2; paneth cell-enhanced expression protein; SAP30-binding protein; Transcriptional regulator protein HCNGP; HCNGP; HTRG; HTRP
Species:  
Source:  
loading...
    loading...
Art. -Nr.: HY-P706029
Reinheit:  ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: Cyclin-dependent kinase 11B; cell division cycle 2-like protein kinase 1; CLK-1; cell division protein kinase 11B; Galactosyltransferase-associated protein kinase p58/GTA; PITSLRE serine/threonine-protein kinase CDC2L1; p58 CLK-1; CDC2L1; CDK11; PITSLREA; Cyclin-L2; paneth cell-enhanced expression protein; SAP30-binding protein; Transcriptional regulator protein HCNGP; HCNGP; HTRG; HTRP
Species:  
Source:  
loading...
    loading...